For Use of Anonymous Retinal Data in AI Model Training and Research
Last Updated: 01-06-2025
This Agreement governs the collection, storage, and use of anonymous retinal image data (“Data”) for the purpose of training and validating artificial intelligence (AI) and decision-support models aimed at detecting and diagnosing diabetic retinopathy and related retinal diseases.
By providing, contributing, or otherwise permitting access to the Data, you (“Data Provider”) acknowledge and agree to the terms set forth herein.
“Anonymous Data”: Data that has been stripped of personal identifiers in compliance with applicable privacy regulations and cannot reasonably be linked to an identifiable individual.
“Research Purposes”: Use of the Data for training, testing, validating, and improving AI systems and diagnostic models.
“We,” “Us,” or “Our”: LUCYDX LLC.
The Data will be used solely for:
Training, validating, and testing AI algorithms.
Research and development of diagnostic decision-support tools.
Publication of aggregated and anonymized research findings in academic or clinical contexts.
The Data will not be sold, licensed, or otherwise transferred for unrelated commercial purposes.
All Data must be fully anonymized before submission. No personal identifiers (names, dates of birth, addresses, medical record numbers, etc.) may be included.
We will implement industry-standard technical and organizational safeguards to prevent unauthorized access, disclosure, or misuse of the Data.
The Data will not be re-identified or combined with other data sets for the purpose of identifying individuals.
The Data Provider retains ownership rights to the Data.
By submitting Data, the Data Provider grants Us a non-exclusive, royalty-free, worldwide, perpetual license to use, process, and analyze the Data for Research Purposes.
Any AI models, algorithms, or intellectual property developed through use of the Data will be owned exclusively by Us.
All Data usage will comply with applicable laws and regulations, including but not limited to HIPAA (Health Insurance Portability and Accountability Act) in the United States, GDPR (General Data Protection Regulation) in the European Union, and any relevant local health privacy legislation.
Data Providers are responsible for ensuring that their provision of Data is lawful and that they have obtained all necessary rights and permissions.
We may share aggregated, anonymized insights derived from the Data with research partners, regulators, or in academic publications.
Individual Data sets will not be disclosed to third parties without prior written consent from the Data Provider.
The Data is provided “as is” without warranties of any kind.
We shall not be held liable for any damages arising from the use, misuse, or inability to use the Data or resulting AI models.
This Agreement remains in effect unless terminated by either party with written notice.
Upon termination, We will cease using the Data but may retain and continue using AI models or aggregated insights already developed.
This Agreement will be governed by and construed in accordance with the laws of the United States of America and the state of Delaware.
For questions about this Agreement, please contact: